Mevis-DV Tablet is a fixed-dose combination product containing Drotaverine (80mg) and Mefenamic Acid (250mg) indicated for the treatment of various pain and inflammatory conditions, including dysmenorrhea, primary dysmenorrhea, and other menstrual disorders. Drotaverine, a direct smooth muscle relaxant, exerts a relaxant effect on uterine smooth muscle, thereby reducing menstrual cramps and spasms. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), possesses anti-inflammatory and analgesic properties, which contribute to its efficacy in reducing pain, inflammation, and fever. The combination of these two agents in Mevis-DV Tablet provides a synergistic effect, offering enhanced therapeutic benefits in the management of menstrual disorders. The tablet is suitable for adult women experiencing menstrual cramps, heaviness, and discomfort, as well as those experiencing primary dysmenorrhea, endometriosis, and other menstrual disorders. It is essential to follow the recommended dosage and consult a healthcare professional before taking Mevis-DV Tablet, especially in patients with a history of gastrointestinal disorders or kidney disease.